BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9452266)

  • 21. Granulocyte-macrophage colony stimulating factor (GM-CSF) in the treatment of hematological malignancies.
    Löwenberg B; de Greef GE; Wielenga JJ
    Anticancer Drugs; 1993 May; 4 Suppl 1():17-20. PubMed ID: 8347852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of cytokines in the treatment of acute myelocytic leukemia: a critical review.
    Geller RB
    J Clin Oncol; 1996 Apr; 14(4):1371-82. PubMed ID: 8648396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timed-sequential chemotherapy with concomitant granulocyte colony-stimulating factor for newly diagnosed de novo acute myelogenous leukemia.
    He XY; Pohlman B; Lichtin A; Rybicki L; Kalaycio M
    Leukemia; 2003 Jun; 17(6):1078-84. PubMed ID: 12764371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte-macrophage colony-stimulating factor in post-remission therapy of acute myeloid leukemia.
    Sousa AB; Fernandes JP; Costa I; Ferreira G; Nunes O; Ribeiro P; Neves A; Cruz E; Aveiro F; Rodrigues AS; Bernardo M; Conduto A; Gonçalves AJ; Monteiro A; Sousa M; Soares VH; Veiga J; Gouveia J
    Hematol Cell Ther; 1998 Apr; 40(2):63-6. PubMed ID: 9615248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997.
    Cripe LD; Rader K; Tallman MS; Gordon MS; Paietta E; Bennett J; Neuberg D; Litzow MR; O'brien TE; Rowe JM
    Leuk Res; 2006 Jul; 30(7):823-7. PubMed ID: 16413056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot remission induction therapy with idarubicin, plus an intensified dose of ara-C and priming with granulocyte colony-stimulating factor for acute myeloid leukemia.
    Baek JH; Sohn SK; Kim DH; Kim JG; Yang DH; Kim YK; Lee JJ; Kim HJ
    Acta Haematol; 2007; 117(2):109-14. PubMed ID: 17135724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential clinical applications of rhGM-CSF in acute myeloid leukemia based on its biologic activity and receptor interaction.
    Lanza F; Rigolin GM; Castagnari B; Moretti S; Castoldi G
    Haematologica; 1997; 82(2):239-45. PubMed ID: 9175331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Granulocyte macrophage--colony stimulating factor (GM-CSF) as adjunct in induction therapy of acute myeloid leukemia.
    Gangadharan VP; Prakash NP; Jayasree K; Nayak N
    Indian J Cancer; 1999 Mar; 36(1):32-7. PubMed ID: 10810552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
    Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
    Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
    Zittoun R; Suciu S; Mandelli F; de Witte T; Thaler J; Stryckmans P; Hayat M; Peetermans M; Cadiou M; Solbu G; Petti MC; Willemze R
    J Clin Oncol; 1996 Jul; 14(7):2150-9. PubMed ID: 8683249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy-related Acute Myeloid Leukemia after the Long-term Administration of Low-dose Etoposide for Chronic-type Adult T-cell Leukemia-lymphoma: A Case Report and Literature Review.
    Shimada N; Ohno N; Tanosaki R; Fuji S; Suzuki Y; Yuji K; Uchimaru K; Tojo A
    Intern Med; 2017; 56(14):1879-1884. PubMed ID: 28717086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical effect of granulocyte colony-stimulating factor on neutrophils and leukemic cells in myelogenous leukemia: analysis.
    Ishikawa J; Yoshimura M; Matsunashi T; Tominaga N; Teshima H; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
    Jpn J Clin Oncol; 1991 Jun; 21(3):169-75. PubMed ID: 1719259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of granulocyte-macrophage colony-stimulating factor activity in the supernatant of the cultured leukemic cells of adult T-cell leukemia with eosinophilia].
    Mori N; Murakami S; Wake A; Tsukada J; Nakata K; Misago M; Oda S; Eto S
    Rinsho Ketsueki; 1993 Jan; 34(1):74-8. PubMed ID: 8450613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of endogenous thrombopoietin and granulocyte-colony stimulating factor in patients with acute or lymphoma type adult T-cell leukemia during multicycle chemotherapy.
    Lin XY; Hanada S; Uozumi K; Utsunomiya A; Suzuki S; Shimotakahara S; Takeuchi S; Takatsuka Y; Arima T
    Leuk Lymphoma; 2002 Feb; 43(2):343-9. PubMed ID: 11999567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma M-CSF as an indicator of response to chemotherapy in adult T cell leukemia patients.
    Yamada Y; Ohmoto Y; Yamamura M; Murata K; Tsukasaki K; Jo T; Momita S; Kohno T; Hata T; Kamihira S; Tomonaga M
    Leuk Lymphoma; 1996 Aug; 22(5-6):457-61. PubMed ID: 8882959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte-colony stimulating factor-induced proliferation of primary adult T-cell leukaemia cells.
    Matsushita K; Arima N; Ohtsubo H; Fujiwara H; Hidaka S; Kukita T; Suruga Y; Fukumori J; Matsumoto T; Kanzaki A; Yawata Y; Tanaka H
    Br J Haematol; 1997 Mar; 96(4):715-23. PubMed ID: 9074411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
    Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
    Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.